GlaxoSmithKline Consumer Healthcare

980 Great West Road, Brentford, Middlesex, TW8 9GS
Telephone: +44 (0)208 0475 000
Medical Information Direct Line: +44 (0)500 888 878
Medical Information e-mail: customer.relations@gsk.com
Customer Care direct line: +44 (0)208 0472 700
Medical Information Fax: +44 (0)208 0476 860

Summary of Product Characteristics last updated on the eMC: 23/04/2007
SPC Alphosyl HC Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

ALPHOSYL HC CREAM


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredientsQuantity (% w/w)

Alcoholic extract of coal tar 5.0

Hydrocortisone 0.5

Allantoin 2.0


Go to top of the page
3. PHARMACEUTICAL FORM

Cream for topical application.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the treatment of psoriasis by topical administration.


Go to top of the page
4.2 Posology and method of administration

For all patients, apply sparingly twice daily to psoriatic plaques and rub in well until the cream is no longer visible.

Not recommended for children under 5 years.


Go to top of the page
4.3 Contraindications

Tuberculosis or fungal lesions of the skin (eg. athletes foot), acne vulgaris, herpes simplex (cold sores), vaccinia or varicella or a history of hypersensitivity to any of the ingredients.

Not for use in sore, acute or pustular psoriasis or in the presence of infection.


Go to top of the page
4.4 Special warnings and precautions for use

For external use only, avoid contact with the eyes.

Discontinue use if sensitivity occurs. Avoid mucosa, genital or rectal areas and broken or inflamed skin

Use sparingly.

The following results of steroid use are uncommon at this dosage, however:

- When used over large areas or for prolonged periods systemic side effects can result.

- Under occlusive dressings or in intertriginous areas, topical steroids may cause skin atrophy manifesting as striae, thinning and telangiectasia.

- Viral, bacterial or fungal infection of the skin may be substantially exacerbated by topical steroid treatment unless accompanied by appropriate therapy.

- Wound healing can be significantly retarded.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Topical administration of corticosteroids to pregnant animals can cause abnormality of foetal development. Topical steroids should not be used extensively in pregnancy, ie in large amounts or for long periods because of the risk of teratogenic effects or significant absorption causing suppression of the HPA axis.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

skin irritation and acne like eruptions, photosensitivity.

Hypersensitivity reactions may occasionally occur. May cause allergic reactions (possibly delayed) in certain individuals.


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Coal tar is a standard antipruritic and keratoplastic agent used in the treatment of psoriasis and other skin disorders. Allantoin is a chemical debrider; it stimulates cell proliferation, epithelization and granulation, and hence hastens wound healing. Steroids are standard in the topical treatment of various skin disorders.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

Several animal studies have demonstrated that the non-carcinogenic toxicity profile of medicinal coal tar is acceptable.

Coal tar preparations have been shown to contain chemicals with a known relationship to the development of malignant tumours in experimental models. Animal studies, where coal tar has been applied topically, have consistently given positive results.

However, it is consistently clear that epidemiological studies in man have not confirmed this carcinogenic potential. Where isolated case studies have related the use of medicinal coal tar to tumour induction, well controlled retrospective studies have not confirmed the relationship. The individual case reports are not well documented as to causation.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Beeswax

Cetyl alcohol

Citric acid

Corn oil

Glyceryl monostearate

Isopropyl palmitate

Mineral oil and lanolin alcohol

Methyl paraben

Oleyl alcohol

Propyl gallate

Propyl paraben

PEG 400 dilaurate

Sodium citrate

Squalane

Lecithin

Triethanolamine

Phenylethyl alcohol

Water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

18 months


Go to top of the page
6.4 Special precautions for storage

Store between 4°C and 25°C.


Go to top of the page
6.5 Nature and contents of container

Alphosyl HC Cream is packaged in decorated, collapsible, aluminium tubes with a phenolic/epoxy resin liner and latex end seal. The nozzle is closed with a high density polyethylene screw on cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

For all patients, apply sparingly twice a day to psoriatic plaques and rub in well until the cream is no longer visible. Alphosyl HC Cream is not recommended for children under 5 years.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Stafford-Miller Limited

980 Great West Road

Brentford

Middlesex TW8 9GS

Trading as: GlaxoSmithKline Consumer Healthcare


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0036/0026R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

17/01/1997


Go to top of the page
10. DATE OF REVISION OF THE TEXT

March 2002



More information about this product

Link to this document from your website: http://emc.medicines.org.uk/medicine/13756/SPC/Alphosyl HC Cream/


Active Ingredients/Generics

 
   hydrocortisone
   coal tar extract
   allantoin


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk